Inventor · disambiguated record
Schaked Omer Halperin
Also filed as: HALPERIN SCHAKED OMER
6 granted patents·4 pending applications·38 citations·filing 2018–2025
80Inventor score
Files withUNIV CALIFORNIA4REWRITE THERAPEUTICS INC3INTELLIA THERAPEUTICS INC1REPLACE THERAPEUTICS INC1TRANSIT THERAPEUTICS INC1
Top patents by PatentIndex Score
10 records- 0193US11352623B2Methods and compositions for directed genome editingREWRITE THERAPEUTICS INC·Filed 2021·Granted Jun 7, 2022·8 cites·28 claims
- 0293US11193123B2Methods and compositions for directed genome editingREWRITE THERAPEUTICS INC·Filed 2021·Granted Dec 7, 2021·27 cites·28 claims
- 0392US11649443B2RNA-guided endonuclease fusion polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2021·Granted May 16, 2023·2 cites·24 claims
- 0484US12415993B2RNA-guided endonuclease fusion polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2023·Granted Sep 16, 2025·0 cites·27 claims
- 0583US12497601B2RNA-guided endonuclease fusion polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2023·Granted Dec 16, 2025·0 cites·23 claims
- 0680US11649442B2RNA-guided endonuclease fusion polypeptides and methods of use thereofUNIV CALIFORNIA·Filed 2018·Granted May 16, 2023·1 cites·12 claims
- 0774US2023076357A1Methods and Compositions for Directed Genome EditingINTELLIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0871US2022090064A1Methods and compositions for directed genome editingREWRITE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 0963US2023151353A1Direct replacement genome editingREPLACE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1055US2025179468A1Direct replacement genome editingTRANSIT THERAPEUTICS INC·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Schaked Omer Halperin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →